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Genome-wide association study for acute otitis
media in children identiﬁes FNDC1 as disease
contributing gene
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Acute otitis media (AOM) is among the most common pediatric diseases, and the
most frequent reason for antibiotic treatment in children. Risk of AOM is dependent on
environmental and host factors, as well as a signiﬁcant genetic component. We identify
genome-wide signiﬁcance at a locus on 6q25.3 (rs2932989, Pmeta¼ 2.15 1009), and show
that the associated variants are correlated with the methylation status of the FNDC1
gene (cg05678571, P¼ 1.43 1006), and further show it is an eQTL for FNDC1
(P¼ 9.3 1005). The mouse homologue, Fndc1, is expressed in middle ear tissue and its
expression is upregulated upon lipopolysaccharide treatment. In this ﬁrst GWAS of AOM and
the largest OM genetic study to date, we identify the ﬁrst genome-wide signiﬁcant locus
associated with AOM.
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O
titis media (OM) is among the most common pediatric
diseases, and the most frequent reason for antibiotic
treatment, in children. Interrelated phenotypes include
acute OM (AOM), recurrent AOM and OM with effusion.
Among OM phenotypes, AOM is deﬁned by the presence of
(purulent) ﬂuid in the middle ear accompanied by earache,
bulging of the tympanic membrane and fever, usually preceded by
an upper respiratory tract infection1–3, which is the type of OM
most frequently encountered by pediatricians, and constitutes the
largest number of OM patients. The etiology of OM is one of
complex associations between environmental, pathogen, host and
genetic risk factors4. Heritability is well-established in sibling,
twin and family studies, with the fraction of phenotype variability
attributed to genetic variation (h2) estimated between 0.22 and
0.74 (refs 5–8).
The genetic susceptibility loci for OM are not well understood.
Candidate gene studies, based on biological plausibility of the
genes and evidence from model organisms, have examined the
association of some relevant genes to OM and yielded signiﬁcant
associations for 420 genes including several interleukin (IL)
genes, mucin genes, TLR4, FBXO11, TNFa. (reviewed by Rye
et al.9). However, as with most candidate gene studies,
results are conﬂicting with only a small proportion of the
discoveries replicating in independent studies. Recently, agnostic
discovery approaches have been adopted to identify the
genetic susceptibility loci underlying OM. Single-nucleotide
polymorphisms (SNPs) at several loci have been reported to be
associated with OM, such as those at 10q26.3, 19q13.43, 17q12,
10q22.3, 2q31.1 for association with chronic and recurrent
OM10–13, 2p23.1 (genes CAPN14, GALNT14) and 20q11.21
(BPIFA gene) for association with OM in general14. None of these
signals broke the threshold of genome-wide signiﬁcance
(Po5 10 8), likely due to the small sample size and limited
number of genetic variants examined. A recent study of
OM via exome sequencing identiﬁed the cosegregation of a rare
duplication variant in gene A2ML1 with OM in a Filipino
pedigree, and additional A2ML1 variants were found in
otitis-prone American children15, but these variants were all of
very low frequency which could not account for the high
prevalence of OM. In addition, there has been no genetic study
speciﬁcally examining the susceptibility loci for AOM.
We perform genome-wide association studies (GWAS) to
identify susceptibility loci for AOM. In the meta-analysis of two
discovery cohorts including 825 cases, 7,936 controls and 1,219
cases, 1067 controls respectively, we identify a genome-wide
signiﬁcant locus at on 6q25.3. We subsequently replicate the
association in an additional cohort of 293 cases of AOM and
1,719 controls. We further reveal signiﬁcant correlation
between the associated variant and the methylation status and
expression levels of the ﬁbronectin type III domain containing
1 (FNDC1) gene. Additionally, we demonstrate that the mouse
homologue Fndc1 is expressed in the middle ear tissue and is
being upregulated under proinﬂammatory conditions, such as
lipopolysaccharide treatment, suggesting FNDC1 is the causal
gene underlying the association.
Results
GWAS identiﬁes AOM susceptibility locus. We performed a
GWAS on AOM with age of onset o3 years old. Both patients
and controls were recruited and their genomic DNA (gDNA)
was genotyped at the Children’s Hospital of Philadelphia (CHOP)
and the Generation R Study (Supplementary Figs 1 and 2,
Supplementary Tables 1 and 2). In the discovery phase, all
samples were genotyped using Illumina HumanHap550-V1/V3
or HumanHap610 or 660-Quad DNA Bead Chips. After quality
control ﬁltering, a total of 825 cases and 7,936 controls of
European descent retained for analysis at CHOP together with
1219 cases and 1,067 controls at Generation R. Logistic regression
analysis under an additive model was performed to assess the
association between SNP genotype and AOM at each individual
site, including the ﬁrst three principal components and sex as
covariates (Supplementary Fig. 3). The residual genomic inﬂation
factor was 1.00 for analysis at CHOP and 1.01 at the Generation
R Study (Supplementary Fig. 4). The site-speciﬁc GWAS were
subsequently meta-analysed to combine the 460,000 exclusively
non-imputed SNPs (minor allele frequency (MAF)40.01) shared
by the two centers, using a sample-size based ﬁxed-effect model.
One variant on 6q25.3 with MAF 0.13 in controls (rs2932989,
Pmeta¼ 4.36 10 08) (Table 1, Supplementary Fig. 5) surpassed
the genome-wide signiﬁcance threshold (Po5 10 08) follow-
ing the meta-analysis. The associated locus was subsequently
imputed using the 1,000Genome data set as a reference. A total of
77 genotyped and imputed SNPs in this region showed suggestive
association with P values o5 10 05 (Fig. 1a, Supplementary
Table 3).
We subsequently investigated whether the association signal
could be replicated in an independent cohort. An additional 293
cases of AOM and 1,719 controls were recruited at CHOP and
genotyped for this purpose, using the Illumina HumanOmniEx-
press-12 v1 chip (Supplementary Table 2). The replication
samples were mainly of European and African American ancestry
with a minority of subjects of Asian and Hispanic ancestry
(Supplementary Fig. 3). The ﬁrst three principal components and
sex were included as covariates in the association analysis. The
resulting genomic inﬂation factor was 1.01 (Supplementary
Fig. 4), suggesting population stratiﬁcation was well controlled.
While the top SNP from the discovery cohort, rs2932989 is not
directly genotyped on the HumanOmniExpress chip, two proxy
SNPs in strong linkage disequilibrium (r2¼ 1) with rs2932989
both showed association with AOM (Po0.05) (Supplementary
Table 4) in the replication cohort and approached genome-wide
signiﬁcance in the discovery cohort based on imputed genotype
data (P¼ 7.49 10 07 for rs578217 and P¼ 9.79 10 07
for rs419009, Supplementary Table 3). Direct interrogation
of rs2932989 following imputation of the replication cohort
Table 1 | Genome-wide signiﬁcant association of 6q25.3 with acute otitis media.
SNP Chr Pos (hg19) Gene A1/A2 MAF
cases/controls
Stage ORCHOP
(95% CI)
PCHOP ORGenR
(95% CI)
PGenR Pmeta
rs2932989 6 159699284 FNDC1 T/G 0.17/0.13 Discovery 1.41 (1.23, 1.62) 1.46e06 1.25 (1.05, 1.48) 1.02e02 4.36e08*
Replication 1.35 (1.05, 1.73) 1.55e02
Combined 2.15e09w
A1, minor allele; A2, major allele; Chr, chromosome; CI, conﬁdence interval; MAF, minor allele frequency; OR, odds ratio; P, P value; Pos, position; SNP, single-nucleotide polymorphism.
*P value of meta-analysis at discovery stage.
wP value of meta-analysis of all cohorts.
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conﬁrmed the association P¼ 0.0155 (Table 1). Further
meta-analysis of the discovery cohorts and the replication cohort
yielded a P value of 2.15 10 09 for top SNP rs2932989.
We, therefore, demonstrate the ﬁrst genome-wide signiﬁcant
association of common variation with susceptibility to AOM and
replicate the ﬁnding in an independent pediatric AOM cohort.
Test statistics for suggestive loci and candidate genes. In
addition to the genome-wide signiﬁcant association at 6q25.3
locus, we also observed suggestive evidence for association
at eight additional loci (5 10 8oP valueo5 10 5;
Supplementary Fig. 6 and Supplementary Table 5), among which,
KIF21B, CACNA1S, CRHR2, BDKRB2 and TPM4 have been
reported to be involved in pathogenesis of autoimmune disease,
inﬂammatory disease or response to bacterial infection16–22.
Interrogating our GWAS data set for candidate genes that have
been previously proposed to be involved in pathogenesis of OM,
we found 45 out of 82 genes demonstrated evidence of nominally
signiﬁcant association, with intragenic SNPs or nearby SNPs of
P valueo0.05; Supplementary Table 6), such as SMAD2, SMAD4,
NELL1. BMP5, GALNT13 which are involved in transforming
growth factor (TGF)-beta signalling, pro-inﬂammatory cytokine
IL1B and its inhibitor IL1RN, receptor for ﬁbroblast growth factor
(FGFR1). TGF-beta, IL-1, ﬁbroblast growth factor (FGF) all have
been reported to regulate FNDC1 expression23,24.
FNDC1 is expressed in mouse middle ear tissue. The associated
variants at 6q25.3 locus map to an linkage disequilibrium block
that contains one gene, the FNDC1 (Fig. 1). Expression data from
both mouse and human tissues (http://www.informatics.jax.org;
http://www.eurexpress.org; GTEx database25) indicate FNDC1 is
expressed in different tissue types with high levels in
mesenchymal stem cells, synovial membrane, fetal cartilage,
thyroid gland, adipose tissue and others (Supplementary Fig. 7;
Supplementary Data 1). In addition, Fndc1 expression was also
found in pharyngeal tissues including the oral epithelium, next to
esophagus tissue, lips, palate and salivary glands (Supplementary
Table 7). Database ‘Bgee: Gene Expression Evolution’ (http://
bgee.unil.ch/)26 included three studies detecting the expression of
Fndc1 in mice ears and one study showed its expression in inner
ears27–29; additional data from the Shared Harvard Inner-Ear
Laboratory database (https://shield.hms.harvard.edu) indicate
Fndc1 expression is present in both the cochlea and utricle. We
further conducted experiments to examine the expression of
Fndc1 in mouse middle ears. By western blotting, we observed
not only the expression of Fndc1 in C57/BL6 mice middle ears
but also the upregulation of Fndc1 upon lipopolysaccharide
treatment compared with control treated with PBS alone
(Supplementary Fig. 8).
AOM variants correlate with FNDC1 expression and methylation.
In addition to the expression of FNDC1 in tissues of relevance
to the phenotype, data from the GTEx database25 also
indicates the AOM associated SNP, rs2932989, is an expression
quantitative trait locus (eQTL) for FNDC1 in esophageal smooth
muscle (Supplementary Fig. 9) (P¼ 9.3 10 05).
Evidence of an association between the AOM-associated
variants and FNDC1 expression was further strengthened
following the analysis of methylation data. We found signiﬁcant
association between methylation probe cg05678571 (chr6:
159,660,813 159,660,813, Fig. 1a) and rs2932989 (beta¼  0.200,
P¼ 1.43 10 6, Fig. 1b) and even a stronger association
between cg05678571 and SNP rs2501175 (beta¼  0.31,
P¼ 7.27 10 15; rs2501175 meta-analysis P¼ 2.89 10 07)
(Supplementary Fig. 10 and Supplementary Table 3). The
genomic distance between cg05678571 and rs2932989 is 38.5 kb
and that between cg05678571 and rs2501175 is 53.6 kb, both of
which are o1Mb, the average size of topologically associating
domains and gene co-expression clusters in human30. Checking
the 3D Genome Browser (http://www.3dgenome.org)31–33, we
found that the above two GWAS SNPs and the methylation probe
are indeed located in the same topologically associating domain
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Figure 1 | The association statistics of locus 6q25.3 with acute otitis media and correlation with methylation status in gene FNDC1. (a) The
regional association plot at locus 6q25.3. The SNP chromosomal location on genome build hg19 is indicated on the x axis and the negative log10 of P value
for each SNP is plotted on the left-hand y axis. Association statistics were from the meta-analysis of the two cohorts in the discovery phase. The most
associated SNP (rs2932989) is shown as purple dot and the other SNPs including both genotyped SNPs and imputed SNPs are coloured according to their
linkage disequilibrium with SNP rs2932989. The recombination rates are shown as blue lines. The plot was generated with software LocusZoom70. The
position of the methylation probe cg05678571 is indicated by a grey dot. (b) M-values for methylation probe cg05678571 are plotted against the additive
genotype at SNP rs2932989. Dark horizontal lines in the boxplots represent the median of the group, the boxes represent the 25–75% quantiles, and the
whiskers of the boxplot extend beyond those quartiles to 1.5 times the interquartile range. Data outside those ranges are represented by points (open
circles). Red diamonds indicate the means of each group, and the red text is the mean±s.d. of each group. The number of individuals with each additive
genotype of minor allele T is indicated below the x axis.
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(Supplementary Fig. 11), suggesting plausible interactions
between these loci.
As expected34, the eQTL and methylation data were inversely
correlated. The minor allele (T) at rs2932989 was positively
correlated with the FNDC1 expression levels (Supplementary
Fig. 9) and negatively correlated with methylation status of probe
cg05678571 in FNDC1 (Fig. 1b) indicating that methylation of
CpG islands in FNDC1 results in reduced expression. Finally, we
used Haploreg35 to determine if any of the 77 AOM-associated
SNPs at the locus overlaps with protein binding domains. Two of
the SNPs were found to have CTCF and EGR1 bound based
on the ENCODE data36 (Supplementary Table 8). The same
binding motifs were also predicted at the location of the
rs2932989-associated methylation probe (cg05678571 CTCF at
chr6:159660813-159660831 and EGR1 at chr6:159660869-
159660882) suggesting a role for these proteins in the
modulation of FNDC1 expression.
Discussion
In summary, we have performed the ﬁrst GWAS of AOM and the
largest genetic study of OM to date, the most common medical
problem encountered by general pediatric practitioners. We
discovered genome-wide signiﬁcance at a locus on 6q25.3 that
contains the FNDC1 gene and replicated the association in an
independent pediatric cohort. We further show that the mouse
homologue of this gene is expressed in the middle ear and is
upregulated upon lipopolysaccharide treatment. In addition to
the tissue expression patterns, the eQTL and methylation data
also implicate FNDC1 as the causal gene underlying the
association.
FNDC1 gene encodes a ﬁbronectin type III domain containing
protein. Fibronectin is an important type of extracellular matrix
proteins, which interacts with integrins and is involved in cell
adhesion, migration, proliferation and differentiation37. Only a
few studies have been reported regarding the function of FNDC1,
which suggest that FNDC1 is involved in multiple cellular
processes. FNDC1 was expressed in heart tissue, with the role of
activating G-protein signalling by interacting with Gbg38. This
interaction also affects CX43 function and cell permeability, thus
sensitizing cells to hypoxic stress in rat neonatal cardiomyocytes
and playing an essential role in hypoxia induced apoptosis39.
While the biological function of FNDC1 has not been well
studied, it has been shown that FNDC1 has a role in
inﬂammation. FNDC1 was ﬁrst identiﬁed as a differentially
expressed mRNA from human dermal ﬁbroblasts. Its expression
level is increased following treatment with TGF-b, IL-1 and
TNF-a23. Partially unfolded type III ﬁbronectin module has been
shown to induce the expression of IL-8 and TNF-a via activation
of the NF-kB signalling pathway, suggesting that ﬁbronectin
matrix remodelling may impact cytokine expression40,41. Both
tissue remodelling and increased levels of cytokines are involved
in AOM42,43. In line with these observations, in our study, the
minor allele (T allele) of SNP rs2392989 confers a higher risk of
AOM and is correlated with a lower level of methylation at
cg05678571 in FNDC1, as well as higher expression of FNDC1. In
addition, Fndc1 expression in mouse middle ear was upregulated
upon lipopolysaccharide treatment, which is known to be a
potent inducer of inﬂammation, stimulating TGF-b, TNF-a
and IL-1 signalling44–46. Consistent with the association of
FNDC1 with OM and its expression being modulated by
lipopolysaccharide, several important players involved in these
signalling pathways of inﬂammatory responses also showed at
least nominal association with OM in our GWAS. FNDC1 is also
one of the differentially expressed genes in primary central
nervous system lymphoma compared with normal lymph node
tissues47, with possible involvement in lymphocyte production.
Therefore, the cumulative evidence from literature and the results
from our GWAS and mouse experiments suggest that FNDC1
may have a role in the pathogenesis of OM, likely through altered
immune or inﬂammatory response.
The diverse signalling processes that FNDC1 is involved in are
inter-related. In an environment of inﬂammation, hypoxia is
typical, with decreased level of oxygen and glucose, as well as
increased level of inﬂammatory cytokines48. Hypoxia and
hypoxia-inducible factor have an important role in chronic OM
and myringotomy reduces hypoxia and inﬂammation, which are
demonstrated by mouse model49,50. Hypoxia-inducible factor is
of well-known function in hypoxia induced apoptosis51. Hypoxia
signalling is linked to innate immunity, adaptive immunity and
infections. Genes functioning in hypoxia signalling interact
with players of NF-kB pathway. (reviewed by Eltzschig and
Carmeliet52) G protein signalling is of critical roles in various
immune functions53. The FNDC1 interactor Gbg has important
functions in immune response. For example, it activates
PI3Kgamma, regulating inﬂammation through neutrophil
recruitment54,55. It also activates RhoGef, involved in
lymphocyte chemotaxis and actin polymerization56. It would be
interesting to examine whether FNDC1 is involved in AOM
pathogenesis through any of these signalling pathways.
Among the genes that have been previously proposed to be
involved in OM pathogenesis, we found more than half of
them exhibited nominally signiﬁcant association, suggesting
consistency between genetic studies and/or with results from
model organism studies. It is not surprising that some of the
candidate genes did not show signiﬁcant association, considering
the following possible reasons. In our GWAS, we focused on a
more deﬁned phenotype of early-onset AOM, which is different
from the phenotypes examined in many of the previous OM
genetic studies including OM in general, chronic OM or OM
with effusion. In addition, different ethnicity of the study
population is another inﬂuential factor to consider. Furthermore,
polymorphisms of candidate genes, proposed based on evidence
from differential gene expression, molecular, cellular functions
and rodent model studies, may not always present an effect large
enough to be captured by GWAS.
The strength of the study lies in the largest sample size and
dense genome-wide SNP coverage. Furthermore, we have
balanced power and optimal quality control. Compared with
previous efforts, this study applied more stringent quality control
and more robust correction for population substructure. Indeed,
by performing principal-component analysis (PCA) to identify
participants of European ancestry, followed by a second PCA on
this selected population, we were able to more thoroughly correct
for population stratiﬁcation. By a well-deﬁned phenotype in both
populations we were able to combine data from two studies of
different designs. Limitation herein is severity of disease, as in one
population cases consisted of children who were speciﬁcally
diagnosed with AOM, likely the more severe episodes, whereas
the other population used extensive questionnaires, discovering
even the mildest of episodes. These differences were resolved by
the increased power of combining the studies, underlined by
results showing the same direction of effect and similar effect size
between both. Furthermore, the P value of homogeneity test in
our meta-analysis is 40.9 for the genome-wide signiﬁcant
SNP rs2932989, which indicates that there is no suggestion of
between-study heterogeneity.
This study provides evidence of a genetic component
inﬂuencing susceptibility to AOM in children. By gaining better
understanding of the complex polygenetic pathogenesis of AOM,
we hope to be able to develop more speciﬁc therapies and to
ultimately learn which children are most susceptible to this
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disease, where earlier clinical intervention may have the most
impact.
Methods
Statement of ethics. This study was conducted at the Center for Applied
Genomics (CAG) at the CHOP, and in the Generation R Study (GenR) at Erasmus
University Medical Center, The Netherlands. The study was approved by the
Institutional Review Board at the CHOP, and the Medical and Ethical Review
Committee of the Erasmus University Medical Center. Written informed consent
was obtained from all participants.
CHOP population and phenotype deﬁnition. All children in the CAG biobank
recruited from the Greater Philadelphia area with both phenotypic and genotypic
data available were eligible for this study. Case-status for AOM was deﬁned using
ICD-9 codes (Supplementary Fig. 1). Exclusion criteria were established, deﬁned by
speciﬁc diseases with strong correlation to AOM due to speciﬁc defects in anatomy
and/or strongly related to susceptibility to upper respiratory tract infections
(Supplementary Table 1). Subjects in the CAG database with no history of middle
ear disease were labelled as controls (Supplementary Table 2). DNA samples at
CHOP were obtained via whole blood venipuncture or saliva samples collected at
CHOP and associated health centers in the Philadelphia metropolitan area.
The Generation R Study population and phenotype deﬁnition. The Generation
R Study is a population-based prospective cohort study from fetal life until
adulthood57. We deﬁned cases and controls using survey data on OM, fever with
earache, otorrhea, use of eardrops per subscription by family practitioner or ear,
nose and throat (ENT) surgeon. Questionnaires were sent at the ages of 2, 6, 12,
24 and 36 months. As such, case status was established for the phenotype of
AOM up to the age of three years, and control status (Supplementary Fig. 2, and
Supplementary Table 2). Only children of European ancestry were considered,
and exclusion criteria were applied (Supplementary Table 1). At Generation R,
whole-blood samples were collected postpartum from the umbilical cord, or at
5 years from venipuncture.
Discovery phase genotyping and quality control. gDNA, extracted following the
phenol-chloroform protocol, was genotyped using Illumina HumanHap550-V1/V3
or HumanHap610 or 660-Quad DNA Bead Chips at CHOP and the Generation R
Study. Quality control was performed through PLINK (software release v1.07;
http://pngu.mgh.harvard.edu/purcell/plink/)58. Samples with a call rate below 98%
at CHOP and below 97.5% at Generation R, or, at either center, with ambiguous
sex detected by PLINK or excess of autosomal heterozygosity (Fomean-4 s.d.),
were excluded. Only SNPs that were common to all chip types were included in
analysis. SNPs with call rate o95% were excluded, as well as SNPs with MAF
o0.01, and Hardy–Weinberg equilibrium P valueso10 5. PLINK was used for
PCA at the Generation R Study, whereas, at CHOP, PCA was conducted using
software Eigenstrat59. We excluded subjects that were not of European ancestry
and repeated the PCA in the remaining samples to derive the principal components
to use as covariates for the association analysis as described below. Genome-wide
identity-by-descent analysis was performed using PLINK. Duplicated or cryptically
related samples were detected as PI_HAT X0.1875; and one from each pair was
excluded from further analysis.
Association analysis and meta-analysis. After quality control ﬁltering, a total of
825 cases, 7,936 controls and 507,300 SNPs were left for association analyses at
CHOP. At Generation R, 469,664 SNPs were available after quality control ﬁltering,
a total of 1,219 cases, 1,067 controls. Association analysis was performed at the two
sites separately. At both sites, logistic regression analysis under the additive model
was performed to assess the association between SNP genotype and AOM.
Principal components (PC) were implemented in our model: AOM¼ SNPþ
PC1þPC2þ PC3þ sex. Association analyses were carried out via PLINK at
CHOP, and using GRIMP60,61 at the Generation R Study. We completed a GWAS
at each center and meta-analysed SNPs shared by the two centers. As such,
B460,000 genotyped SNPs were available for meta-analysis. We performed
sample-sized weighted meta-analyses using METAL software package62.
Replication analysis. To increase power, we included all AOM cases
that passed the phenotype selection criteria and were genotyped on the
HumanOmniExpress-12v1 array to form the replication cohort. Similarly controls
were genotyped on the same array type and had no history of middle ear disease.
Samples underwent the same quality control as the discovery cohorts. Logistic
regression analysis was conducted including the ﬁrst three PCs and sex as
covariates.
Regional imputation. The CHOP discovery and replication cohorts were
prephased using SHAPEIT63,64 version 2, followed by genotype imputation of
chromosome 6 using IMPUTE 2 (refs 65,66) against the 1,000 Genome Phase 3
reference (https://mathgen.stats.ox.ac.uk/impute/1000GP%20Phase%203%
20haplotypes%206%20October%202014.html). Association testing of the imputed
genotypes was carried out in SNPTEST65 V2. using the missing data likelihood
score test, including sex and the ﬁrst three principal components as covariates.
We excluded SNPs with info scoreo0.8 or with Hardy–Weinberg equilibrium-test
P valueo1 10 06.
Analysis of methylation data. Genome-wide methylation proﬁles were
generated on a total of 854 subjects recruited by the CAG on the Inﬁnium
HumanMethylation450 BeadChip Kit according to the manufacturers’ protocols.
gDNA was isolated from peripheral blood mononuclear cells. Methylation data
were exported from the Illumina GenomeStudio, as GenomeStudio output
text ﬁles containing probe level summarized information. The GenomeStudio
output ﬁles were loaded into the R statistical package (r-project.org) using the lumi
package67,68. The lumi package was used for preprocessing of data, which involved
quantile colour balance adjustment and background level correction and simple
scaling normalization (ssn). M-value density and CpG-site intensity were plotted
after normalization, and two aberrant chips were removed. Principle component
analysis identiﬁed 425 subjects of European ancestry, 374 African Americans,
20 East Asians, and 24 Hispanics among these subjects. Methylation probes known
to overlap with common SNPs, were identiﬁed and removed using the IMA
R package69. M-values (the log2 ratio between the methylated and unmethylated
probe intensities) were extracted and stored as a matrix. Additive genotypes at
rs2932989 for subjects of European ancestry were extracted from existing
genotyping data using PLINK. There are a total of 402 subjects of European
ancestry without missing genotype at rs2932989 and extreme outlier values of
methylation M-values (Zmedian M-value of the genotype group±3 s.d.).
Methylation data in gene FNDC1 were analysed as the response variable in a linear
regression, with genotype at rs2932989 as the predictor variable among these
402 subjects. Sex, age, and 10 genotype-derived principle components were
included as covariates. Linear regression and generation of boxplots was performed
using base packages in R.
Animals. The Institutional Animal Care and Use Committee of the CHOP
approved all animal studies. C57/BL6 female mice were used in the study.
Mice were randomly distributed into two groups and deeply anesthetized, using
ketamine (100mg per kg) and xylazine (10mg per kg) via intraperitoneal injection.
The experimental group received lipopolysaccharide (2mg per ml) in PBS, 20 ul
per ear derived from Salmonella typhimurium (Sigma-Aldrich), and 0.01M PBS
was injected into the middle ears of the control group. Mice were killed at third day
after injection of lipopolysaccharide or PBS.
Western blot analysis. For western blot analysis, mice middle ear tissue,
including the epithelial lining was removed from animals after decapitation and
sonicated in ice-cold NP40 lysis buffer (Invitrogen) containing protease inhibitor
(Calbiochem). Proteins extracts were boiled for 5min in SDS– polyacrylamide gel
electrophoresis sample buffer (0.125M Tris-HCl, 20% glycerol, 4% SDS, and
0.005% bromo-phenol blue) for denaturation. A 20-mg protein sample was
separated on a 4–12% NuPAGE Bis-Tris gel (Novex), transferred overnight to a
nitrocellulose membrane (Invitrogen), and blocked overnight with 3% BSA
tris-buffered saline with Tween (10mM Tris-HCl (pH 7.5), 150mM NaCl, and
0.05% Tween 20). The membrane was cut in half with the upper half of the
membrane incubated with rabbit anti-FNDC1 polyclonal antibody (H-65;
sc-382009) at 1:1000 dilution and the lower half of the membrane probed with
rabbit anti-b-Actin polyclonal antibody (N-21; sc-130656) at 1:1000 dilution at
room temperature for one hour. Subsequently, the membranes were washed for
three times and incubated in a 1:10,000 dilution of horseradish peroxidase–
conjugated anti-rabbit secondary antibody (Promega) for 1 h at room temperature
and washed again three times. WesternBright enhanced chemiluminescence (ECL)
detection system (Advansta) was used to detect bound antibody. Then the band
intensities were measured with Image J software (NIH Shareware).
Data availability. The data are available from the corresponding authors upon
request.
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